Former Novo CEO Lars Rebien appointed executive chair at Ferring

Lars Rebien Sørensen, the former long-standing CEO of Novo Nordisk, joined Ferring Pharmaceuticals as chair of the board in summer last year, and has now been appointed its executive chair, an amalgamation of a chief executive and chair position, although he retains most of his chair duties. The news comes with a record-breaking annual report from the company.

Chair of the Novo Nordisk Foundation, Lars Rebien Sørensen, has been appointed executive chair at pharmaceutical firm Ferring Pharmaceuticals | Photo: Finn Frandsen/Politiken/Ritzau Scanpix

The chair of the Novo Nordisk Foundation, Lars Rebien Sørensen, who stood at the helm of Novo Nordisk for many years, has been appointed Executive Chairman at Ferring Pharmaceuticals, a company press release has announced.

The appointment comes a little under a year after Rebien Sørensen was given the title of chairman at the company’s board, when he took over from Frederik Paulsen, who had been at the post since 1998.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs